Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Masafumi Yokota"'
Autor:
Tomohiro Asai, Masafumi Yokota, Hideki Isomura, Hiroyuki Koide, Naoyuki Sakurai, Ayaka Okamoto, Hidenori Ando, Takehisa Dewa, Naoto Oku
Publikováno v:
Journal of Pharmaceutical Sciences.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed90bc6c2026156269a992a409a8a4dd
https://doi.org/10.1016/j.xphs.2023.02.017
https://doi.org/10.1016/j.xphs.2023.02.017
Autor:
Masafumi Yokota, Tomohiro Asai, Hiroyuki Koide, Takehisa Dewa, Hidenori Ando, Mamoru Nango, Noriyuki Maeda, Norihito Yonenaga, Hiroki Kato, Naoto Oku
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 11:185-194
PTEN-positive tumors are not susceptible to the treatment with rapamycin, an inhibitor of the mammalian target of rapamycin (mTOR). Here, we determined the susceptibility of PTEN-positive cells to small interfering RNA for mTOR (si-mTOR) by using a n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab1d9b86d9afcf67d08a868d5de24e39
https://doi.org/10.1016/j.nano.2014.09.003
https://doi.org/10.1016/j.nano.2014.09.003
Publikováno v:
The Journal of Gene Medicine. 15:375-383
Background We previously developed a microRNA (miRNA) delivery system by using dicetyl phosphate-tetraethylenepentamine-based polycation liposomes (TEPA-PCL), applied it to miR-92a delivery, and demonstrated its gene-silencing potential and effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::011619ad193cefc8dc794314fb8a9ec4
https://doi.org/10.1002/jgm.2744
https://doi.org/10.1002/jgm.2744
Publikováno v:
Therapeutic Innovation & Regulatory Science. 51:9-10
The founding industry members (European Federation of Pharmaceutical Industries and Associations [EFPIA], Japanese Pharmaceutical Manufacturers Association [JPMA], and Pharmaceutical Research and Manufacturers of America [PhRMA]) of the International
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42491ade05d0cdc9c5dfdb8002aca656
https://doi.org/10.1177/2168479016665877
https://doi.org/10.1177/2168479016665877
Autor:
Kenmei Takaichi, Tetsuo Tagami, Keitaro Yokoyama, Yoshifumi Ubara, Hideyuki Katori, Akira Yamada, Fumi Takemoto, Shigeko Hara, Masafumi Yokota, Shunya Uchida, Junichi Hoshino, Yoshifuru Tamura, Naoki Sawa
Publikováno v:
The American Journal of Medicine. 118:181-184
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d4bb4646dbb0d14acdb4e7716e2d2a3
https://doi.org/10.1016/j.amjmed.2004.07.049
https://doi.org/10.1016/j.amjmed.2004.07.049
Autor:
Kenmei Takaichi, Masafumi Yokota, Hirokatu Murata, Yoshifumi Ubara, Fumi Takemoto, Shigeru Shibata, Tetsuo Tagami, Junichi Hosino, Shigeko Hara, Tadahiro Nishi, Akiko Fujii, Naoki Sawa, Hideyuki Katori
Publikováno v:
Internal Medicine. 43:248-252
A 53-year-old woman presented with oliguria, urinary frequency, abdominal pain and severe edema of the lower extremities. Her serum creatinine was 8.1 mg/dl. Computed tomographic and ultrasonographic studies showed a severely dilated urinary bladder,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db6168ef1d0f6bdc06de6a5b676a8138
https://doi.org/10.2169/internalmedicine.43.248
https://doi.org/10.2169/internalmedicine.43.248
Autor:
Hideyuki Katori, Junichi Hoshino, Fumi Takemoto, Masafumi Yokota, Yoshihisa Mikami, Naoki Sawa, Shigeo Hara, Shigeko Hara, Yoshifumi Ubara, Tetsuo Tagami
Publikováno v:
Internal Medicine. 42:345-350
We treated a patient with an unusual bone disease at least partly associated with Chinese herbs. Seven years after 65-year-old man had begun to consume Chinese herbs, multifocal osteoarthralgias were noted, and the patient was hospitalized for renal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b326f324771a18dc8d39e8509cec5470
https://doi.org/10.2169/internalmedicine.42.345
https://doi.org/10.2169/internalmedicine.42.345
Autor:
Hideyuki Katori, Yoshifumi Ubara, Keihachirou Kuzuhara, Sumio Inoue, Masafumi Yokota, Akira Yamada, Fumi Takemoto, Shigeko Hara, Naoki Sawa, Tetsuo Tagami
Publikováno v:
American Journal of Kidney Diseases. 39:571-579
Kidneys of patients with autosomal dominant polycystic kidney disease (ADPKD) usually continue to increase in size, even after patients begin dialysis therapy, and the mass effects may lead to severe complications. Such external conventional therapie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::222b9c0dfebeb5cb00874eeb6d479c0c
https://doi.org/10.1053/ajkd.2002.31407
https://doi.org/10.1053/ajkd.2002.31407
Autor:
Takao Nagashima, Akira Yamada, Akiko Kitamura, Fumi Takemoto, Hideyuki Katori, Masafumi Yokota, Tetsuo Tagami, Yoshifumi Ubara, Mitsuru Hara, Shigeko Hara, Kiyotaka Nagahama
Publikováno v:
Clinical and Experimental Nephrology. 6:49-57
A 73-year-old man was admitted to our hospital because he had developed loss of appetite, abnormal behaviors, and consciousness disturbances that had begun in late February 1998. On admission, a renal biopsy was performed because of progressive deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::462b969384b5a70c40e6d7fbff379c05
https://doi.org/10.1007/s101570200007
https://doi.org/10.1007/s101570200007
Autor:
Masafumi Yokota, Shigeko Hara, Sumio Inoue, Yoshifumi Ubara, Keihachirou Kuzuhara, Fumi Takemoto, Akira Yamada, Toshikazu Imai, Tetsuo Tagami, Hideyuki Katori
Publikováno v:
Nihon Toseki Igakkai Zasshi. 33:1381-1388
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fdea5cae7d0499b0934cc3cf08d1634
https://doi.org/10.4009/jsdt.33.1381
https://doi.org/10.4009/jsdt.33.1381